Anthrax: MMWR References
MMWR is a CDC publication addressing new developments in public health.
- Inhalation Anthrax Associated with Dried Animal Hides --- Pennsylvania and New York City, 2006
MMWR 2006 Mar 17;55(10):280-282.
PDF (363 KB/32 pages) -
Follow-Up of Deaths Among U.S. Postal Service Workers Potentially Exposed to Bacillus anthracis—District of Columbia, 2001–2002
MMWR 2003 Oct 3;52(39):937-938.
PDF (470 KB/20 pages) -
Notice to Readers: Occupational Health Guidelines for Remediation Workers at Bacillus anthracis-Contaminated Sites—United States, 2001–2002
MMWR 2002 Sep 6;51(35):786-789.
PDF (220 KB/24 pages) -
Notice to Readers: Protecting Building Environments from Airborne Chemical, Biologic, or Radiologic Attacks
MMWR 2002 Sep 6;51(35):789.
PDF (220 KB/24 pages) -
Notice to Readers: Status of U.S. Department of Defense Preliminary Evaluation of the Association of Anthrax Vaccination & Congenital Anomalies
MMWR 2002 Feb 15;51(6):127.
PDF (204 KB/24 pages) -
Notice to Readers: Evaluation of Postexposure Antibiotic Prophylaxis to Prevent Anthrax
MMWR 2002 Jan 25;51(3):59.
PDF (248 KB/24 pages) -
Investigation of Bioterrorism-Related Anthrax – Connecticut, 2001
MMWR 2001 Dec 7;50(48):1077-1079.
PDF (144 KB/24 pages) -
Use of Onsite Technologies for Rapidly Assessing Environmental Bacillus anthracis Contamination on Surfaces in Buildings
MMWR 2001 Dec 7;50(48):1087.
PDF (144 KB/24 pages) -
Investigation of Bioterrorism-Related Inhalational Anthrax – Connecticut, 2001
MMWR 2001 Nov 30;50(47):1049-1051.
PDF (252 KB/28 pages) -
Adverse Events Associated with Anthrax Prophylaxis Among Postal Employees – New Jersey, New York City, & the District of Columbia Metropolitan Area, 2001
MMWR 2001 Nov 30;50(47):1051-1054.
PDF (252 KB/28 pages) -
Investigation of Bioterrorism-Related Anthrax, 2001
MMWR 2001 Nov 16;50(45):1008-1010.
PDF (262 KB/32 pages) -
Interim Recommendations for Antimicrobial Prophylaxis for Children & Breastfeeding Mothers & Treatment of Children with Anthrax
MMWR 2001 Nov 16;50(45):1014-1016.
PDF (262 KB/24 pages) -
Investigation of Bioterrorism-Related Anthrax & Adverse Events from Antimicrobial Prophylaxis
MMWR 2001 Nov 9;50(44):973-976.
PDF (194 KB/32 pages) -
Considerations for Distinguishing Influenza-Like Illness from Inhalational Anthrax
MMWR 2001 Nov 9;50(44):984-986.
PDF (194 KB/32 pages) -
Interim Guidelines for Investigation of & Response to Bacillus anthracis Exposures
MMWR 2001 Nov 9;50(44):987-990.
PDF (194 KB/32 pages) -
Investigation of Bioterrorism-Related Anthrax & Interim Guidelines for Clinical Evaluation of Persons with Possible Anthrax
MMWR 2001 Nov 2;50(43):941-948.
PDF (219 KB/32 pages) -
Updated Recommendations for Antimicrobial Prophylaxis Among Asymptomatic Pregnant Women After Exposure to Bacillus anthracis
MMWR 2001 Nov 2;50(43):960.
PDF (219 KB/32 pages) -
Interim Recommendations for Protecting Workers from Exposure to Bacillus anthracis in Work Sites in which Mail Is Handled or Processed
MMWR 2001 Nov 2;50(43):961.
PDF (219 KB/32 pages) -
Investigation of Bioterrorism-Related Anthrax & Interim Guidelines for Exposure Management & Antimicrobial Therapy, October 2001
MMWR 2001 Oct 26;50(42):909-919.
PDF (213 KB/32 pages) -
Recognition of Illness Associated with the Intentional Release of a Biologic Agent
MMWR 2001 Oct 19;50(41):893-897.
PDF (168 KB/20 pages) -
Use of Anthrax Vaccine in the United States, ACIP Recommendations
MMWR Recommendations & Reports 2000 Dec 15;49(RR-15):1-20.
PDF (227 KB/39 pages) -
Surveillance for Adverse Events Associated with Anthrax Vaccination – U.S. Department of Defense, 1998-2000
MMWR 2000 Apr 28;49(16):341-345.
PDF (286 KB/24 pages)
Get email updates
To receive email updates about this page, enter your email address:
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - Contact CDC-INFO
